Exclusive Summary

• • Next-generation lipid management product
• • Hit the unmet needs: It can simultaneously reduce two key lipid parameters.
• • Promising in vivo data in NHP: at least comparable to combination efficacy and duration of Inclisiran and internally developed LPA siRNA

Asset Materials

Contact Us for Full Materials